EH

Elaine Hamm

COO

12 past transactions

Pamlico Biopharma

Series A in 2015
Pamlico BioPharma, Inc. develops fully-human monoclonal antibodies (hmAb) for the rapid diagnosis and treatment of infectious diseases and cancer. Pamlico’s lead program is focused on severe pneumonia caused by Streptococcus pneumoniae (SPN), and is in preclinical IND-directed activities for a mAb cocktail and a companion point-of-care (POC) diagnostic against three serotypes that account for over 40% of SPN infections. Pamlico was founded on technologies from the Oklahoma Medical Research Foundation (OMRF) and from Emory University, and is anticipated to enter clinical trials in late 2015.
Otologic Pharmaceutics, Inc. is a company committed to developing treatments for acute hearing loss to reduce the development of permanent hearing disorders. OPI’s lead program HPN1010, an oral medication to treat acute hearing loss, will enter clinical trials in 2014. Initial research focuses on Noise Induced Hearing Loss. We will continue to work to expand the applicability of HPN1010 to treat hearing loss from other causes, such as Cisplatin Induced Hearing loss.

Knewton, Inc.

Series F in 2016
Knewton's mission is to personalize learning for the world. Teachers, schools, and education companies around the world use Knewton to power digital course materials that dynamically adapt to each student’s unique needs. Knewton provides students with tailored recommendations for exactly what to study, teachers with analytics to better support each student, and publishers with content insights to develop more effective digital products. Knewton was founded in 2008 and has offices in New York City, London, Tokyo, Singapore, and Dubai. Knewton has been recognized globally as a “Technology Pioneer” (World Economic Forum in Davos) and several times as one of the top 10 most innovative companies in education (Fast Company).

New Edge Networks

Series A in 1999
New Edge Networks is a provider of wholesale DSL services in small and mid-sized markets.
SigTuple Technologies Private Limited focusses on developing solutions for the automated analysis of medical images and data to aid diagnosis. It offers a peripheral blood smear analyzer that automates differential counts, as well as provides a screening solution for various parasitic infections (malaria), diseases (anemia), and cancerous cells; radiology solutions; and a screening tool to detect pre-cancerous cells in pap smear slides. The company was founded in 2015 and is based in Bengaluru, India.

Coremetrics

Series C in 2001
Coremetrics is a provider of digital marketing optimization solutions and web analytics. Its solutions are designed to generate high return on online marketing investments.

ROI Direct.com

Venture Round in 2000
Founded in June of 1999, ROI Direct offers e-commerce site development and hosting, e-marketing program design and execution, and online customer care solutions tailored to Their clients’ needs. They provide application services, 24x7 systems management, account support, feature upgrades, and shared use of Their multi-million dollar systems infrastructure for less than Their clients’ typical costs of a single IT employee. By customizing Their re-usable set of advanced applications, They’re also able to deliver these solutions in a fraction of the time of in-house or competing third-party solutions.

Artimi

Series A in 2004
Artimi a fables semiconductor company, engages in the development, marketing, and sale of semiconductors, software, and reference designs for the delivery of high speed wireless connectivity in portable consumer electronics devices. The company offers silicon solutions for high bandwidth wireless connectivity based on ultra wideband technologies. Its products include MAC controllers, wireless USB evaluation kits, wireless USB adaptor reference design kits, hard disk drive reference design kits, and printer reference design kits.

Synereca Pharmaceuticals, Inc.

Debt Financing in 2014
Synereca Pharmaceuticals, Inc. develops orally active drugs that restore the effectiveness of existing antibiotics. Its portfolio includes prototypic RecA inhibitors, which target various pathogenic bacteria/E. coli, including those responsible for lung, urinary tract, and skin infections, as well as weaponizable gram-positive and gram-negative pathogens through various bactericidal antibiotics. The company was incorporated in 2009 and is based in Chapel Hill, North Carolina.

ItemField

Series B in 2004
ItemField is a provider of real-time, bi-directional, XML based data transformation software. ItemField's innovative ContentMaster software suite uses a patented new parsing-by-example technology that - for the first time - allows for the transformation of data via XML, from any data format to any other, with no programming required.

Synereca Pharmaceuticals, Inc.

Venture Round in 2015
Synereca Pharmaceuticals, Inc. develops orally active drugs that restore the effectiveness of existing antibiotics. Its portfolio includes prototypic RecA inhibitors, which target various pathogenic bacteria/E. coli, including those responsible for lung, urinary tract, and skin infections, as well as weaponizable gram-positive and gram-negative pathogens through various bactericidal antibiotics. The company was incorporated in 2009 and is based in Chapel Hill, North Carolina.

Quokka Sports

Post in 2000
Quokka Sports, Inc. provides sports entertainment services for the global digital world. The company operates through two divisions: Qmedia, a media production division; and Qtech, a live content technology solutions division. QMedia's principal activities include the acquisition and control of digital rights; production of live sports and entertainment content; publishing and production of web content such as website development for live events, content production, and website maintenance; and creative sponsorship campaign development and sales. QTech develops and manages the company's proprietary Live_IP technology and services that focus on delivering real-time and near real-time immersive media content for the internet, broadband, interactive and enhanced TV, and wireless platforms. The Live_IP platform consists of two primary components, a near real-time content viewer and a live content publishing system. These tools offer content producers, a browser-based publishing platform for creating, editing, assembling, and laying out media-rich content into overlapping content layers that aid content producers in the complete production of projects.